US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Zomedica Corp.

0.1350

+0.00181.35%

Volume:583.60K

Turnover:77.15K

Market Cap:132.29M

PE:- -

High:0.1400

Open:0.1332

Low:0.1280

Close:0.1332

52wk High:0.1580

52wk Low:0.0151

Shares:979.95M

Float Shares:943.24M

Volume Ratio:0.40

T/O Rate:0.06%

Dividend:- -

Dividend Rate:- -

ROE:-52.41%

ROA:-11.42%

PB:1.11

PE(LYR):- -

Loading ...

Overview Company News Filings

Zomedica Showcases R&D Strategy in Investor Webinar

Zomedica Signs Contract Manufacturing Agreement with Rahm Sensor Development

Zomedica Unveils Digital Innovation Strategy in Investor Webinar

Zomedica Partners with Prime Video to Feature Pet Wellness Tech in Holiday Film Merv

Zomedica Corp. Senior Vice President of Sales Russell Kevin Klass Acquires Common Shares

Zomedica Corp. Hosts "Friday at Four" Webinar Featuring Strategic Overview and Q3 Review

Zomedica Corp. Senior Vice President Russell Kevin Klass Acquires Common Shares

Zomedica Corp. Senior Vice President of Sales Russell Kevin Klass Acquires Common Shares

Zomedica Corp. reports Q3 revenue of $8.1 million, up 16% year over year

Zomedica Corp. Expands TRUFORMA Platform with Feline Diagnostics for Cobalamin & Folate Assay

Zomedica Corp. Releases Document on TRUVIEW Digital Cytology Microscope Innovation

Zomedica Corp. Expands Canadian Distribution with UXR for Veterinary Solutions

Zomedica Corp. Expands UK Market with Strategic Distribution Partnership with Pioneer Veterinary Products

Zomedica Corp. Partners with VerticalVet to Provide Advanced Veterinary Technologies to Over 2,600 Clinics Nationwide

Russell Kevin Klass, Sr Vice President of Sales, Reports Acquisition of Common Shares in Zomedica Corp

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ZOMDF/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ZOMDF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZOMDF\",,,,,undefined,":{"symbol":"ZOMDF","market":"US","secType":"STK","nameCN":"Zomedica Corp.","latestPrice":0.135,"timestamp":1771016400000,"preClose":0.1332,"halted":0,"volume":583601,"delay":15,"changeRate":0.013513513513513483,"floatShares":943240860,"shares":979949668,"eps":0,"marketStatus":"Closed","change":0.0018,"latestTime":"02-13 16:00:00 EST Delay","open":0.1332,"high":0.14,"low":0.128,"amount":77150.76717900002,"amplitude":0.09009,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771318800000},"marketStatusCode":5,"adr":0,"exchange":"OTCQB","adjPreClose":0.1332,"volumeRatio":0.400678},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZOMDF\",,,,,undefined,":{"symbol":"ZOMDF","floatShares":943240860,"roa":"-11.42%","roe":"-52.41%","lyrEps":0,"volumeRatio":0.400678,"shares":979949668,"dividePrice":0,"high":0.14,"amplitude":0.09009,"preClose":0.1332,"low":0.128,"week52Low":0.0151,"pbRate":"1.11","psRate":"4.49","week52High":0.158,"institutionHeld":0,"latestPrice":0.135,"eps":0,"divideRate":0,"volume":583601,"delay":15,"open":0.1332,"prevYearClose":0.10175,"prevWeekClose":0.1201,"prevMonthClose":0.1261,"prevQuarterClose":0.1017,"fiveDayClose":0.1201,"twentyDayClose":0.1468,"sixtyDayClose":0.093},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ZOMDF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-15","symbol":"ZOMDF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ZOMDF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ZOMDF\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ZOMDF\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609757379","title":"Zomedica Showcases R&D Strategy in Investor Webinar","url":"https://stock-news.laohu8.com/highlight/detail?id=2609757379","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609757379?lang=en_us&edition=fundamental","pubTime":"2026-02-05 19:30","pubTimestamp":1770291041,"startTime":"0","endTime":"0","summary":"Zomedica Corp. will host its next \"Fourth Friday at Four\" investor webinar on Friday, February 27, 2026, at 4:00 p.m. Eastern Time. The event, titled \"Inside Innovation: Advancing Animal Health Through Research & Development,\" will focus on the company's R&D strategy, its expanding product portfolio, and long-term growth objectives. The session will include prepared remarks and a Q&A, providing insights into Zomedica's innovation pipeline and a behind-the-scenes look at its Plymouth facility. Registration for the event is available online.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zomedica Corp. published the original content used to generate this news brief via ACCESS Newswire  on February 05, 2026, and is solely responsible for ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL4c72Vq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZOMDF","BK4082"],"gpt_icon":0},{"id":"2605981014","title":"Zomedica Signs Contract Manufacturing Agreement with Rahm Sensor Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2605981014","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605981014?lang=en_us&edition=fundamental","pubTime":"2026-01-22 19:30","pubTimestamp":1769081431,"startTime":"0","endTime":"0","summary":"Zomedica Corp. announced that it has entered into a contract manufacturing and service agreement with Rahm Sensor Development. Under the agreement, Zomedica will manufacture Rahm's Cell-Guardian, a personnel monitoring device designed for high-risk environments, and provide engineering services and customer support. The partnership is expected to generate incremental, contract-based revenue for Zomedica and expand its revenue streams beyond animal health by utilizing existing manufacturing and engineering capabilities.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zomedica Corp. published the original content used to generate this news brief via ACCESS Newswire  on January 22, 2026, and is solely responsible for the information contai","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nNDL3nRl95:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZOMDF","BK4082"],"gpt_icon":0},{"id":"2603769016","title":"Zomedica Unveils Digital Innovation Strategy in Investor Webinar","url":"https://stock-news.laohu8.com/highlight/detail?id=2603769016","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603769016?lang=en_us&edition=fundamental","pubTime":"2026-01-14 19:30","pubTimestamp":1768390229,"startTime":"0","endTime":"0","summary":"Zomedica Corp. will host its next \"Fourth Friday at Four\" investor webinar on Friday, January 23, 2026, at 4:00 p.m. Eastern Time. The session, titled \"Digital Advantage: Powering Scalable Growth Through Innovation,\" will focus on the company's expanding digital capabilities and long-term innovation strategy in veterinary diagnostics and therapeutics. The event will feature prepared remarks followed by a question and answer session. Interested participants can register online.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zomedica Corp. published the original content used to generate this news brief via ACCESS Newswire  on January 14, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nNDL9ql6Ch:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ZOMDF"],"gpt_icon":0},{"id":"2590909495","title":"Zomedica Partners with Prime Video to Feature Pet Wellness Tech in Holiday Film Merv","url":"https://stock-news.laohu8.com/highlight/detail?id=2590909495","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590909495?lang=en_us&edition=fundamental","pubTime":"2025-12-11 19:30","pubTimestamp":1765452621,"startTime":"0","endTime":"0","summary":"Zomedica Corp. has announced a collaboration with Prime Video, marking a significant partnership to feature its Assisi and Calmer Canine pet wellness technologies in the new romantic comedy film \"Merv,\" now available on Prime Video. The partnership aims to highlight the emotional connection between people and their pets, with Zomedica's products playing a role in the story centered around a beloved dog named Merv. Both companies will co-promote the film through digital, social, and educational campaigns, targeting pet parents, veterinarians, and investors while raising awareness of Zomedica's mission to advance animal health and wellness.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zomedica Corp. published the original content used ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL7QSSSz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ZOMDF"],"gpt_icon":0},{"id":"2583509677","title":"Zomedica Corp. Senior Vice President of Sales Russell Kevin Klass Acquires Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2583509677","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583509677?lang=en_us&edition=fundamental","pubTime":"2025-11-14 21:18","pubTimestamp":1763126321,"startTime":"0","endTime":"0","summary":"Russell Kevin Klass, Senior Vice President of Sales at Zomedica Corp., has reported the acquisition of common shares of the company, according to a recent SEC filing. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zomedica Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 14, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDL9xsnh6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Zomedica Corp. Senior Vice President of Sales Russell Kevin Klass Acquires Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZOMDF","BK4082"],"gpt_icon":0},{"id":"2582363919","title":"Zomedica Corp. Hosts \"Friday at Four\" Webinar Featuring Strategic Overview and Q3 Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2582363919","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582363919?lang=en_us&edition=fundamental","pubTime":"2025-11-11 19:30","pubTimestamp":1762860620,"startTime":"0","endTime":"0","summary":"Zomedica Corp. will host a special session of its \"Friday at Four\" investor webinar on November 21, 2025, at 4:00 p.m. Eastern Time. The event will feature a strategic overview of the company's product platforms, a review of third-quarter 2025 performance, and a discussion of execution priorities for the remainder of 2025 and into 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zomedica Corp. published the original content used to generate this news brief via ACCESS Newswire  on November 11, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nNDL147Mwf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ZOMDF"],"gpt_icon":0},{"id":"2582385703","title":"Zomedica Corp. Senior Vice President Russell Kevin Klass Acquires Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2582385703","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582385703?lang=en_us&edition=fundamental","pubTime":"2025-11-11 06:21","pubTimestamp":1762813316,"startTime":"0","endTime":"0","summary":"Russell Kevin Klass, Senior Vice President of Sales, reported the acquisition of common shares of Zomedica Corp. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zomedica Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 10, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDLgRlJd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Zomedica Corp. Senior Vice President Russell Kevin Klass Acquires Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ZOMDF"],"gpt_icon":0},{"id":"2581346438","title":"Zomedica Corp. Senior Vice President of Sales Russell Kevin Klass Acquires Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2581346438","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581346438?lang=en_us&edition=fundamental","pubTime":"2025-11-08 05:47","pubTimestamp":1762552047,"startTime":"0","endTime":"0","summary":"Russell Kevin Klass, Senior Vice President of Sales at Zomedica Corp., has reported the acquisition of common shares of Zomedica Corp. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zomedica Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 07, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nNDL9gYgJg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Zomedica Corp. Senior Vice President of Sales Russell Kevin Klass Acquires Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ZOMDF"],"gpt_icon":0},{"id":"2581761160","title":"Zomedica Corp. reports Q3 revenue of $8.1 million, up 16% year over year","url":"https://stock-news.laohu8.com/highlight/detail?id=2581761160","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581761160?lang=en_us&edition=fundamental","pubTime":"2025-11-05 05:12","pubTimestamp":1762290734,"startTime":"0","endTime":"0","summary":"Zomedica Corp. reported revenue of $8.1 million for the three months ended September 30, 2025, a 16% increase from $7.0 million in the same period in 2024. Revenue for the nine months ended September 30, 2025, was $21.6 million, up 11% from $19.4 million for the same period in 2024. The increase in revenue for the quarter was primarily attributed to contract manufacturing and engineering revenue, growth in TRUFORMA product sales-including the launch of new assays-higher consumables sales in existing PulseVet products, initial sales from VETIGEL, and growth in existing Assisi products. Business developments for the period included the commencement of marketing and sales for VETIGEL and the launch of new assays for TRUFORMA products.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nNDLVCsW3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZOMDF","BK4082"],"gpt_icon":0},{"id":"2569579791","title":"Zomedica Corp. Expands TRUFORMA Platform with Feline Diagnostics for Cobalamin & Folate Assay","url":"https://stock-news.laohu8.com/highlight/detail?id=2569579791","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569579791?lang=en_us&edition=fundamental","pubTime":"2025-09-23 18:30","pubTimestamp":1758623417,"startTime":"0","endTime":"0","summary":"Zomedica Corp. has announced the expansion of its TRUFORMA diagnostic platform with the addition of feline testing capability to its cobalamin & folate assay. Initially launched in early 2024 for canine use, this multiplexed assay combines two critical tests in one, allowing veterinarians to perform in-clinic testing for cobalamin and folate, which are essential in diagnosing gastrointestinal conditions. The expansion now enables testing for feline patients, addressing a significant clinical need for timely and accurate results. This advancement allows for the assessment of two important biomarkers at the point of care, delivering reference-lab quality results in under 25 minutes. The addition of feline testing capability to the TRUFORMA platform provides veterinarians with improved diagnostic efficiency and supports enhanced clinical outcomes for feline patients. Results of this new capability were announced at the time of the platform's expansion.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250923:nNDL9NCfKJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZOMDF","BK4082"],"gpt_icon":0},{"id":"2566973804","title":"Zomedica Corp. Releases Document on TRUVIEW Digital Cytology Microscope Innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=2566973804","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566973804?lang=en_us&edition=fundamental","pubTime":"2025-09-12 18:30","pubTimestamp":1757673021,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zomedica Corp. published the original content used to generate this news brief via ACCESS Newswire  on September 12, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250912:nNDL3SKq5h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ZOMDF"],"gpt_icon":0},{"id":"2566770906","title":"Zomedica Corp. Expands Canadian Distribution with UXR for Veterinary Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2566770906","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566770906?lang=en_us&edition=fundamental","pubTime":"2025-09-10 18:30","pubTimestamp":1757500216,"startTime":"0","endTime":"0","summary":"Zomedica Corp., a veterinary health company, has announced an expanded distribution agreement with UXR Inc., a prominent Canadian animal health company. This agreement appoints UXR as the exclusive distributor of Zomedica's PulseVet system and VETGuardian products in Canada, as well as the distributor of the Assisi product line. The collaboration aims to enhance access to Zomedica's advanced therapeutic and monitoring solutions across over 4,000 veterinary practices in Canada. The partnership is expected to support the growing demand for innovative veterinary care solutions in the Canadian market, which is experiencing a projected 7% compound annual growth rate.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zomedica Corp. published th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250910:nNDL3QQYSW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ZOMDF"],"gpt_icon":0},{"id":"2564625033","title":"Zomedica Corp. Expands UK Market with Strategic Distribution Partnership with Pioneer Veterinary Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2564625033","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564625033?lang=en_us&edition=fundamental","pubTime":"2025-09-03 18:30","pubTimestamp":1756895419,"startTime":"0","endTime":"0","summary":"Zomedica Corp., a veterinary health company specializing in point-of-care diagnostic and therapeutic products, has announced a strategic distribution partnership with Pioneer Veterinary Products Limited in the United Kingdom. This agreement aims to expand Zomedica's presence in the UK veterinary market by distributing its TRUFORMA diagnostic platform across England, Scotland, Wales, and Northern Ireland. The partnership will see Pioneer leading sales and support for the small animal market exclusively, while acting as a non-exclusive distributor for equine products. Initially focused on the TRUFORMA system, which provides reference lab-quality results at the point of care for dogs, cats, and horses, the collaboration plans to introduce VETGuardian remote monitoring technology at a later stage. This partnership is set to strengthen Zomedica's European presence and enhance veterinary practices in the UK with innovative tools designed to improve animal health outcomes and practice efficie","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250903:nNDLjyBQL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZOMDF","BK4082"],"gpt_icon":0},{"id":"2560160498","title":"Zomedica Corp. Partners with VerticalVet to Provide Advanced Veterinary Technologies to Over 2,600 Clinics Nationwide","url":"https://stock-news.laohu8.com/highlight/detail?id=2560160498","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560160498?lang=en_us&edition=fundamental","pubTime":"2025-08-19 18:30","pubTimestamp":1755599424,"startTime":"0","endTime":"0","summary":"Zomedica Corp., a veterinary health company, has announced a strategic partnership with VerticalVet, a prominent Group Purchasing Organization in the veterinary industry. This two-year agreement positions Zomedica as a preferred provider of advanced veterinary solutions to VerticalVet's network, which includes over 2,600 independent veterinary practices across the United States. The collaboration will provide VerticalVet members with access to Zomedica's innovative technologies, such as the PulseVet shock wave therapy system, the VETGuardian remote monitoring platform, Assisi tPEMF therapy devices, and Vetigel hemostatic gel. These solutions aim to enhance clinical excellence and operational efficiency in veterinary care. Mark Wainscott, President of VerticalVet, highlighted the partnership's potential to elevate clinical outcomes and support independent practices in delivering superior patient care.Disclaimer: This news brief was created by Public Technologies  using generative artifi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250819:nNDL8f2Ynm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZOMDF","BK4082"],"gpt_icon":0},{"id":"2559623465","title":"Russell Kevin Klass, Sr Vice President of Sales, Reports Acquisition of Common Shares in Zomedica Corp","url":"https://stock-news.laohu8.com/highlight/detail?id=2559623465","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559623465?lang=en_us&edition=fundamental","pubTime":"2025-08-13 00:27","pubTimestamp":1755016066,"startTime":"0","endTime":"0","summary":"Russell Kevin Klass, the Senior Vice President of Sales, reported an acquisition of common shares of Zomedica Corp. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zomedica Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 12, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nNDL76JnmR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZOMDF"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}]}}